{"id":"W2099826019","doi":"10.1016/s0140-6736(11)60936-7","title":"Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial","year":2011,"lang":"en","type":"article","venue":"The Lancet","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"International AIDS Society","keywords":"Rilpivirine; Emtricitabine; Efavirenz; Medicine; Viral load; Internal medicine; Regimen; Reverse-transcriptase inhibitor; Virology; Pharmacology; Human immunodeficiency virus (HIV); Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001872726,0.002423246,0.004603448,0.0005808098,0.0005370455,0.001393228,0.001334038,0.002654717,0.009320301],"category_scores_gemma":[0.002207282,0.001070924,0.002812275,0.000529948,0.001593926,0.001917578,0.0004873265,0.004197021,0.0013275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008404732,"about_ca_system_score_gemma":0.0009111558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001525223,"about_ca_topic_score_gemma":0.003391848,"domain_scores_codex":[0.9992884,0.0003427843,0.00004948935,0.0001427618,0.0000453864,0.0001312861],"domain_scores_gemma":[0.999037,0.000381564,0.0001829857,0.00007922297,0.00004746459,0.0002717697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9903779,0.00176666,0.000109963,0.0004977767,0.0005188864,0.00002286793,0.00003193156,0.000115438,0.0008558814,0.00005668628,0.0002982032,0.005347744],"study_design_scores_gemma":[0.9841291,0.01481565,0.0003517579,0.00002053977,0.0002423659,0.00001203707,0.00001211552,0.000103023,0.00008290848,0.00005555574,0.0001667985,0.000008162213],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.978187,0.01020533,0.0008670268,0.001122734,0.001240171,0.003714491,0.001670343,0.0002406102,0.002752332],"genre_scores_gemma":[0.9765983,0.006417254,0.002143064,0.001678332,0.00087171,0.004851955,0.001148996,0.00004715917,0.006243076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009320301,"threshold_uncertainty_score":0.03117949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04770636682178646,"score_gpt":0.2973200934542903,"score_spread":0.2496137266325038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}